Home

צביעות אבולוציה קפטן ברי magl inhibitor מונה מחסום גקוזי

Representative MAGL inhibitors along with their IC 50 value. | Download  Scientific Diagram
Representative MAGL inhibitors along with their IC 50 value. | Download Scientific Diagram

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on  bone remodelling in healthy and cancer-bearing mice - eBioMedicine
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect

Monoacylglycerol Lipase Inhibitor 21 (MAGL Inhibitor 21, MGL Inhibitor 21,  CAS Number: 1643657-35-5) | Cayman Chemical
Monoacylglycerol Lipase Inhibitor 21 (MAGL Inhibitor 21, MGL Inhibitor 21, CAS Number: 1643657-35-5) | Cayman Chemical

Discovery of Isatin‐Based Carbohydrazones as Potential Dual Inhibitors of  Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Jaiswal - 2022 -  ChemMedChem - Wiley Online Library
Discovery of Isatin‐Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Jaiswal - 2022 - ChemMedChem - Wiley Online Library

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect

MAGL-IN-1 | MAGL Inhibitor | MedChemExpress
MAGL-IN-1 | MAGL Inhibitor | MedChemExpress

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect

Therapeutic endocannabinoid augmentation for mood and anxiety disorders:  comparative profiling of FAAH, MAGL and dual inhibitors | Translational  Psychiatry
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors | Translational Psychiatry

A Schematic model of the effects of MAGL inhibition on the interactions...  | Download Scientific Diagram
A Schematic model of the effects of MAGL inhibition on the interactions... | Download Scientific Diagram

MJN110 | MAGL inhibitor | Cas# 1438416-21-7 - GlpBio
MJN110 | MAGL inhibitor | Cas# 1438416-21-7 - GlpBio

Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive  Group that Is Bioisosteric with Endocannabinoid Substrates - ScienceDirect
Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that Is Bioisosteric with Endocannabinoid Substrates - ScienceDirect

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in  cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect

Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit  of Therapies for Neurological and Neurodegenerative Diseases | HTML
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases | HTML

A) Representative examples of covalent MAGL inhibitors with the... |  Download Scientific Diagram
A) Representative examples of covalent MAGL inhibitors with the... | Download Scientific Diagram

Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit  of Therapies for Neurological and Neurodegenerative Diseases | HTML
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases | HTML

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible  Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from  3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety | Journal of Medicinal  Chemistry
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety | Journal of Medicinal Chemistry

Structural modifications of MAGL inhibitor 144. | Download Scientific  Diagram
Structural modifications of MAGL inhibitor 144. | Download Scientific Diagram

Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in  Experimental Ischemic Stroke | Stroke
Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke | Stroke

Monoacylglycerol lipase (MAGL) as a promising therapeutic target -  ScienceDirect
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect

Structures of representative urea-based MAGL inhibitors and H... | Download  Scientific Diagram
Structures of representative urea-based MAGL inhibitors and H... | Download Scientific Diagram

Potential application of endocannabinoid system agents in neuropsychiatric  and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta  Pharmacologica Sinica
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica

Chemical structures of representative urea-based MAGL inhibitors 22e27... |  Download Scientific Diagram
Chemical structures of representative urea-based MAGL inhibitors 22e27... | Download Scientific Diagram

MJN110 is an Orally Active and Selective Monoacylglycerol Lipase Inhibitor  - Immune System Research
MJN110 is an Orally Active and Selective Monoacylglycerol Lipase Inhibitor - Immune System Research

Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). |  Download High-Resolution Scientific Diagram
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download High-Resolution Scientific Diagram

Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New  Targets for Future Antidepressants | Bentham Science
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants | Bentham Science

Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses  via hippocampal CA1 GABAergic synapses | Molecular Psychiatry
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses | Molecular Psychiatry